Research programme: gynaecological disorder therapeutics - Pivot PharmaceuticalsAlternative Names: PVT 001; PVT 004
Latest Information Update: 30 Dec 2015
At a glance
- Originator Pivot Pharmaceuticals
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Dysmenorrhoea; Hot flashes
Most Recent Events
- 30 Dec 2015 Preclinical trials in Hot flashes in USA (unspecified route)
- 30 Dec 2015 Preclinical trials in Dysmenorrhoea in USA (unspecified route)